These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13150518)

  • 1. A clinical appraisal of pentapyrrolidinium (M&B 2050) in hypertensive patients.
    FREIS ED; PARTENOPE EA; LILIENFIELD LS; ROSE JC
    Circulation; 1954 Apr; 9(4):540-6. PubMed ID: 13150518
    [No Abstract]   [Full Text] [Related]  

  • 2. Action of ecolid in man.
    SMIRK FH; HAMILTON M
    Br Med J; 1956 Feb; 1(4962):319-22. PubMed ID: 13284313
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of hypertension with pentolinium and mecamylamine.
    SEARS HT; SNOW PJ; HOUSTON IB
    Br Med J; 1959 Feb; 1(5120):462-5. PubMed ID: 13629020
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug treatment of hypertension.
    HOOBLER SW; DONTAS AS
    Pharmacol Rev; 1953 Jun; 5(2):135-74. PubMed ID: 13064031
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of arterial hypertension with M & B 2050A (pentapyrrolidinium bitartrate)].
    FERNANDEZ FERRER O; MACIAS CASTRO I; LOPEZ DE LA VEGA R
    Arch Hosp Univ; 1955; 7(2):113-9. PubMed ID: 13269266
    [No Abstract]   [Full Text] [Related]  

  • 6. The drug treatment of severe hypertensive disease, with particular reference to hydralazine and pentapyrrolidinium.
    HOOBLER SW
    Trans Am Coll Cardiol; 1955 Dec; 5():101-6. PubMed ID: 13274398
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical use of pentapyrrolidinium (M & B 2050 A) combined with Rauwolfia serpentina in the treatment of arterial hypertension].
    BLANCO QUINTANA R; MIER PONTE M
    Rev Med Cubana; 1955 Oct; 66(10):741-9. PubMed ID: 13281148
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pentapyrrolidinium (ansolysen) therapy of malignant hypertension].
    VAN DER STRAETEN M
    Belg Tijdschr Geneesk; 1955 Aug; 11(15):759-67. PubMed ID: 13249936
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of hypotensive drugs on renal function in chronic renal disease.
    ABRAHAMS DG; WILSON C
    Lancet; 1957 Jan; 272(6959):68-74. PubMed ID: 13386277
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of hypertension by the ganglion blocking agents, oxaditon & ansolysen].
    CLAUSEN JP
    Ugeskr Laeger; 1957 Oct; 119(40):1310-3. PubMed ID: 13496332
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ganglionblockers and hypertension].
    WILLOCX R; TREMOUROUX J
    Therapie; 1953; 8(3):295-321. PubMed ID: 13136029
    [No Abstract]   [Full Text] [Related]  

  • 12. [Controlled hypotension with depressin and pendiomide].
    BENKE A
    Wien Med Wochenschr; 1953 Mar; 103(10):187-8. PubMed ID: 13078482
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood pressure reduction in arterial hypertension by hexamethonium and pentapyrrolidinium salts.
    SMIRK FH
    Am J Med; 1954 Dec; 17(6):839-50. PubMed ID: 13207165
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of hypertension with reserpine, with reserpine in combination with pentapyrrolidinium, and with reserpine in combination with Veratrum alkaloids.
    DOYLE AE; McQUEEN EG; SMIRK FH
    Circulation; 1955 Feb; 11(2):170-81. PubMed ID: 13231254
    [No Abstract]   [Full Text] [Related]  

  • 15. Sensitivity of autonomic ganglia to hexamethonium in hypertension.
    CONWAY J
    Br Med J; 1953 Apr; 1(4814):814-7. PubMed ID: 13032511
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pentapyrrolidinium (ansolysen) therapy of hypertension].
    PERSSON I
    Ugeskr Laeger; 1954 Nov; 116(45):1601-3. PubMed ID: 13226509
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of hypertension with 3-methyl-pentapyrrolidinium].
    MOELLER J
    Med Klin; 1956 Aug; 51(35):1466-71. PubMed ID: 13358552
    [No Abstract]   [Full Text] [Related]  

  • 18. M. & B. 1863, a homologue of hexamethonium, in treatment of hypertension.
    LOCKET S; SWANN PG; GRIEVE WS; PLAYER HP
    Br Med J; 1952 Feb; 1(4752):254-8. PubMed ID: 14896106
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of ganglion-blocking agents in psychiatry].
    COSSA P; BOUGEANT H; LOMBARD A
    Ann Med Psychol (Paris); 1953 May; 111(1 5):628-33. PubMed ID: 13065864
    [No Abstract]   [Full Text] [Related]  

  • 20. [Problem of hypotension].
    HOCEVAR D
    Acta Chir Iugosl; 1956; 3(1):1-22. PubMed ID: 13326135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.